ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NCT: NCT07453407 · RECRUITING
NCT IDNCT07453407
StatusRECRUITING
Start Date2026-03-05
Completion2038-03
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine (OTHER)
First posted
Last updated
Brief Summary
The overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.
Frequently Asked Questions
What is ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy?
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy is a clinical trial registered under NCT07453407. Current status: RECRUITING.
What is the status of NCT07453407?
The current status of NCT07453407 (ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy) is: RECRUITING.
When did ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy start?
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy started on 2026-03-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.